BIBF 1120 (nintedanib)

nintedanib · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BIBF 1120 (nintedanib), covering 2014-07-18 to 2025-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies [Phase 1]